Left to their own devices
Scandals, recalls, stingy customers, anxious regulators--any one of these would traumatise a chief executive. America's industry for medical devices is suffering from all of them. Omar Ishrak, the new boss of Medtronic, the world's biggest medical-technology company, recently described the problem succinctly to analysts: "There is a lot of work ahead of us." This is a relatively new ailment for the industry. From 1998 to 2005 the use of equipment such as defibrillators and drug-eluting stents expanded rapidly. "It was the age of implantation in this country," explains David Lewis of Morgan Stanley, with companies "sticking things into everybody." Much has changed.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- IOM Identifies GME Problems, Calls for Finance Changes
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- Anatomy of 3 Health System Rebranding Efforts